- About us
- Hospitals and centres
- Patients and visitors
- Join our team
- Get involved
- Clinician resources
- Refer your patient
A record $3.75 million has been awarded to 40 ground-breaking health and medical research projects at the 2019 Metro South Health Research Grants Announcement, thanks to funding from the Metro South Health's Study, Education and Research Trust Account (SERTA), PA Research Foundation (PARF) and National Critical Care Trauma Response Centre (NCCTRC).
Chief Executive Dr Stephen Ayre said Metro South Health (MSH) was committed to building a strong culture of research, innovation and improvement.
“Together with our research partners, MSH has become one of the leading health and medical research organisations in the country,” Dr Ayre said.
“This record $3.75 million investment in research will empower our staff to tackle emerging and current healthcare issues.”
Liver disease, oesophageal cancer, and long-term care for complex rehabilitation patients were the big winners, with three Princess Alexandra Hospital (PAH) projects granted $250,000 from SERTA to develop pioneering methods of care.
“Surgical oncology staff will study the immune responses of long-term oesophageal cancer survivors, to help determine the best treatment options for other patients,” Dr Ayre said.
“Gastroenterology and hepatology clinicians and researchers will work on improving the care of people with non-alcoholic fatty liver disease, including identifying who is at risk of developing the disease.
“And a multidisciplinary team of rehabilitation staff will look at improving the coordination of care for complex brain and spinal injuries rehabilitation patients, who throughout their healthcare journeys receive care from many areas and services.”
A further 10 SERTA-funded, $100,000 grants were also awarded to tackle complex health issues, including post-stroke care, alcoholic hepatitis, head and neck cancer, and post-treatment breast cancer care.
PARF’s $1.35 million funding went to 11 different cancer-focused projects, including prostate, bladder, breast and skin cancer research.
PARF Chief Executive Officer Damian Topp said he was impressed with the quality of submissions.
“The Foundation is committed to funding research that is clinically-led with a focus on translation and is novel in concept, and the projects we are supporting in 2019 all fit these criteria,” Mr Topp said.
The NCCTRC provided two grants worth a combined $100,000 to trauma injury research.